Sign in
SCTX Stock Price, Chart, Stats & News
Scribe Therapeutics Inc.
Save
Scribe Therapeutics Inc. (SCTX) does not currently pay a dividend.
294.51M
Market cap
–
Current P/E
–
Forward P/E
SCTX chart
About
Scribe Therapeutics is a clinical-stage biotechnology company focused on developing in vivo CRISPR-based genetic medicines.
Similar securities
Based on sector and market capitalization
Report issue